| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |